Showing results (1-10 of 790) with videos related to
Sort By:
Pageof 79
Journal of Neurology|September 20, 2008
Advances in the understanding of the mechanism of action of IVIgHans-Peter HartungNeurology(R) Neuroimmunology & Neuroinflammation|June 7, 2020
Ocrelizumab shorter infusion: Primary results from the ENSEMBLE PLUS substudy in patients with MSHans-Peter Hartung, Expert Opinion on Pharmacotherapy|February 25, 2009
High-dose, high-frequency recombinant interferon beta-1a in the treatment of multiple sclerosisHans-Peter HartungJournal of Neurology|September 20, 2005
Early treatment and dose optimisation BENEFIT and BEYONDHans-Peter HartungAnnals of Neurology|October 31, 2007
Toward the development of rational therapies in multiple sclerosis: what is on the horizon?Bernhard Hemmer, Hans-Peter HartungCurrent Opinion in Neurology|March 27, 2025
Multiple sclerosis: advances and challenges in diagnosisSilvia Tenembaum, Hans-Peter HartungJournal of Neurology|April 17, 2002
Chemotherapy-induced peripheral neuropathyStefan Quasthoff, Hans Peter HartungClinical Neuropharmacology|January 12, 2010
Mechanism of action of oral fingolimod (FTY720) in multiple sclerosisJerold Chun, Hans-Peter HartungBiomedical Papers of the Medical Faculty of the University Palacky, Olomouc, Czechoslovakia|July 21, 2020
Multiple sclerosis and COVID-19Jan Mares, Hans-Peter HartungCurrent Opinion in Neurology|March 26, 2025
Update on novel multiple sclerosis treatments: from dismal defeat to scintillating successBruce Cree, Hans-Peter HartungPageof 79